Lacosamide vs. Keppra: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Lacosamide and Keppra. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 167,685 people who take Lacosamide and Keppra, and is updated regularly.
What is Lacosamide?
Lacosamide has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 16,601 Lacosamide users. Check the latest studies of Lacosamide.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
167,685 people who take Lacosamide and Keppra are studied.
Drugs being compared in this study:
- Lacosamide (lacosamide)
- Keppra (levetiracetam)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Lacosamide:
- not at all: 5.17 %
- somewhat: 21.77 %
- moderate: 28.04 %
- high: 31.73 %
- very high: 13.28 %
Keppra:
- not at all: 4.45 %
- somewhat: 13.58 %
- moderate: 22.62 %
- high: 35.27 %
- very high: 24.07 %
Want to compare Lacosamide with Keppra?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Lacosamide (16,551 reports)
- Keppra (70,381 reports)
Browse all side effects of Lacosamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on lacosamide and levetiracetam (the active ingredients of Lacosamide and Keppra, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Dilaudid cause Weight Abnormal? - 4 seconds ago
- Could Prednisone cause Narcotic Intoxication? - 5 seconds ago
- Could Valium cause Dysphoria? - 10 seconds ago
- Could Femara cause Idiopathic Thrombocytopenic Purpura? - 10 seconds ago
- Drug interactions of Xopenex and Zolpidem Tartrate - 10 seconds ago
- Could Lovastatin cause Skin Infection? - 10 seconds ago
- Could Femara cause Alveolar Osteitis? - 16 seconds ago
- Could Ozempic cause Gout Aggravated? - 16 seconds ago
- Could Feldene cause Bone Loss? - 22 seconds ago
- Could Febuxostat cause Weakness? - 32 seconds ago